MAGENTA THERAPEUTICS INC's ticker is MGTA and the CUSIP is 55910K108.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $105,519 | -4.6% | 139,207 | 0.0% | 0.00% | – |
Q1 2023 | $110,628 | +0.6% | 139,207 | -50.0% | 0.00% | – |
Q4 2022 | $109,974 | -43.9% | 278,414 | +100.0% | 0.00% | – |
Q3 2022 | $196,000 | +28.9% | 139,207 | +9.9% | 0.00% | – |
Q2 2022 | $152,000 | -90.5% | 126,707 | -77.1% | 0.00% | – |
Q1 2022 | $1,601,000 | -37.4% | 552,158 | -4.4% | 0.00% | – |
Q4 2021 | $2,559,000 | -34.5% | 577,687 | +7.7% | 0.00% | – |
Q3 2021 | $3,906,000 | -13.1% | 536,483 | +16.8% | 0.00% | – |
Q2 2021 | $4,493,000 | +4.8% | 459,439 | +26.9% | 0.00% | – |
Q1 2021 | $4,286,000 | +51.7% | 362,003 | +0.4% | 0.00% | – |
Q4 2020 | $2,826,000 | +17.2% | 360,462 | +1.7% | 0.00% | – |
Q3 2020 | $2,411,000 | -11.3% | 354,567 | -2.1% | 0.00% | – |
Q2 2020 | $2,719,000 | +22.3% | 362,096 | +2.3% | 0.00% | – |
Q1 2020 | $2,223,000 | -59.7% | 353,965 | -2.6% | 0.00% | – |
Q4 2019 | $5,511,000 | +61.7% | 363,517 | +9.4% | 0.00% | – |
Q3 2019 | $3,408,000 | -16.5% | 332,151 | +20.0% | 0.00% | – |
Q2 2019 | $4,082,000 | +62.8% | 276,715 | +81.7% | 0.00% | – |
Q1 2019 | $2,508,000 | +1859.4% | 152,280 | +576.8% | 0.00% | – |
Q4 2018 | $128,000 | – | 22,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP IV, LLC | 6,758,204 | $49,200,000 | 11.16% |
Aquilo Capital Management, LLC | 3,155,082 | $22,969,000 | 4.17% |
GREAT POINT PARTNERS LLC | 1,170,000 | $8,518,000 | 1.98% |
Casdin Capital, LLC | 3,901,589 | $28,404,000 | 0.71% |
Alphabet Inc. | 3,339,138 | $24,309,000 | 0.58% |
Bleichroeder LP | 434,400 | $3,162,000 | 0.51% |
Palo Alto Investors LP | 432,300 | $3,147,000 | 0.19% |
Integral Health Asset Management, LLC | 90,000 | $655,000 | 0.19% |
Orbimed Advisors | 1,892,953 | $13,781,000 | 0.15% |
HARVARD MANAGEMENT CO INC | 332,610 | $2,421,000 | 0.14% |